Professor, Internal Medicine, University of Maryland School of Medicine
Nephrology
Dr. Matthew R. Weir, MD
|
|
Give Review
Matthew R. Weir, MD is an expert in the field of Nephrology. He went to medical school at University of Virginia School of Medicine. He has 3 awards "CMS Meaningful Use Stage 1 Certification", "Super Doctor" and "Top MD". Matthew Weir is a published doctor. He published 101 publications, including: 'Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage.'
Publications
- Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.
- Response to: Hyperkalaemia in heart Failure: binding the patient to improved treatment?
- Live Donor Renal Transplant With Simultaneous Bilateral Nephrectomy for Autosomal Dominant Polycystic Kidney Disease Is Feasible and Satisfactory at Long-term Follow-up.
- Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association With Target Organ Damage.
- Noteworthy observations in Hypertension from 2015.
- Pharmacokinetics and Tolerability of Intravenous Sildenafil in Two Subjects with Child-Turcotte-Pugh Class C Cirrhosis and Renal Dysfunction.
- The Evaluation and Therapeutic Management of Hypertension in the Transplant Patient.
- Novel RAAS agonists and antagonists: clinical applications and controversies.
- A Prospective Controlled Study of Living Kidney Donors: Three-Year Follow-up.
- Assessment and Management of Hypertension in Transplant Patients.
- Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors.
- Safety Events in Kidney Transplant Recipients: Results from the Folic Acid for Vascular Outcome Reduction in Transplant Trial.
- Urine Neutrophil Gelatinase-Associated Lipocalin and Risk of Cardiovascular Disease and Death in CKD: Results From the Chronic Renal Insufficiency Cohort (CRIC) Study.
- Effect of Canagliflozin on Blood Pressure and Adverse Events Related to Osmotic Diuresis and Reduced Intravascular Volume in Patients With Type 2 Diabetes Mellitus.
- A Pilot Study to Evaluate Renal Hemodynamics in Cirrhosis by Simultaneous Glomerular Filtration Rate, Renal Plasma Flow, Renal Resistive Indices and Biomarkers Measure...
- Safety of medical therapy in patients with chronic Kidney disease and end-stage renal disease.
- Salt, hypertension, and proteinuria in Diabetic nephropathy.
- Vascular stiffness as a surrogate measure of mortality in patients with chronic Kidney disease.
- Effect of Canagliflozin on Serum Electrolytes in Patients With Type 2 Diabetes in Relation to Estimated Glomerular Filtration Rate (eGFR).
- Assessment and Management of Hypertension in Patients on Dialysis.
- Specific Management of Anemia and Hypertension in Renal Transplant Recipients: Influence of Renin-Angiotensin System Blockade.
- Refractory Hypertension: An Important Clinical Phenotype.
- KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD.
- Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 Diabetes and hypertension (a secondary analysis of the BP-CRUSH study).
- Systolic blood pressure and cardiovascular outcomes during treatment of Hypertension.
- Performance of chronic Kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating Kidney function in cirrhosis.
- Blood pressure response With fixed-dose combination therapy: comparing hydrochlorothiazide With amlodipine through individual-level meta-analysis.
- Treated Hypertension and the white coat phenomenon: office readings are inadequate measures of efficacy.
- Efficacy of amlodipine/olmesartan medoxomil ± hydrochlorothiazide in patients aged ⥠65 or < 65 years With uncontrolled hypertension on prior monotherapy.
- Benefits Improvement and Protection Act's Impact on Transplantation Rates Among Elderly MEDICARE Beneficiaries With End-Stage Renal Disease.
- Effects of body size and Hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.
- Angiotensin II Blockade after Kidney Transplantation.
- Antibody-Mediated Allograft Rejection: Morphologic Spectrum and Serologic Correlations in Surveillance and for Cause Biopsies.
- Debate from the 2012 ASH Annual Scientific Sessions: should blood pressure be reduced in hemodialysis patients? con position.
- Urinary Sodium Is a Potent Correlate of Proteinuria: Lessons from the Chronic Renal Insufficiency Cohort Study.
- Thiazide and Thiazide-like Diuretics: An Opportunity to Reduce Blood Pressure in Patients with Advanced Kidney Disease.
- A qualitative study to identify reasons for discharges against medical advice in the cardiovascular setting.
- Influence of Creatinine versus Glomerular Filtration Rate on Non-Steroidal Anti-Inflammatory Drug Prescriptions in Chronic Kidney Disease.
- Role of dietary therapies in the prevention and treatment of Hypertension.
- A 72-Year-Old Woman With Several Months of Weight Loss and Generalized Weakness.
- Renal outcomes in hypertensive Black patients at high cardiovascular risk.
- Genotype-based changes in serum uric acid affect blood pressure.
- Recognizing the link between chronic Kidney disease and cardiovascular disease.
- Determinants of Blood Pressure Response to Low-Salt Intake in a Healthy Adult Population.
- Short-term effects of vitamin D receptor activation on serum creatinine, creatinine generation, and glomerular filtration.
- Body Mass Index-Mortality Paradox in Hemodialysis Patients: Blood Pressure, Blood Volume, and Nutritional Status.
- Optimal Treatment Strategies for Patients With Hypertension and Diabetes: Are Effects on Metabolism Important?
- Management of Hypertension in the transplant patient.
- Angiotensin-converting enzyme inhibitors.
- Hemodynamic Correlates of Proteinuria in Chronic Kidney Disease.
- Varying patterns of the antihypertensive and antialbuminuric Response to higher doses of renin-angiotensin-aldosterone system blockade in albuminuric hypertensive type...
- Acute fall in glomerular filtration rate with renin-angiotensin system inhibition: a biomeasure of therapeutic success?
- A titrate-to-goal study of switching patients uncontrolled on antiHypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochl...
- The author replies:.
- Blood Pressure and Cardiovascular Outcomes in Patients Taking Nonsteroidal Antiinflammatory Drugs.
- The role of angiotensin receptor blockers in Diabetic nephropathy.
- Eosinophilia as an early indicator of pancreatic allograft rejection.
- Mycophenolate mofetil-based immunosuppression with sirolimus in Renal transplantation: a randomized, controlled Spare-the-Nephron trial.
- Erythropoiesis-stimulating agents increase the risk of Acute stroke in patients with chronic kidney disease.
- Leadership message: government and corporate responsibility to work With academia about the obesity epidemic.
- The evolving role of mTOR inhibition in transplantation tolerance.
- Readmissions after unauthorized discharges in the cardiovascular setting.
- Efficacy and safety of carvedilol in treatment of heart failure with chronic Kidney disease: a meta-analysis of randomized trials.
- A randomized, double-blind, forced-titration study to compare olmesartan medoxomil versus losartan potassium in patients With stage 1 and 2 hypertension.
- Effects of high- and low-sodium diets on ambulatory blood pressure in patients With hypertension receiving aliskiren.
- A study of renal outcomes in obese living Kidney donors.
- Pulsatile intermittent intravenous insulin therapy for attenuation of retinopathy and nephropathy in type 1 Diabetes mellitus.
- Optimal blood pressure for a patient with type 2 Diabetes mellitus: insight from the ACCORD study.
- Does blockade of the Renin-Angiotensin-aldosterone system slow progression of all forms of Kidney disease?
- Dietary fructose and elevated levels of blood pressure.
- Hypervolemia and blood pressure: powerful indicators of increased mortality among hemodialysis patients.
- Have we fallen off target With concerns surrounding dual RAAS blockade?
- Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients.
- Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in Diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) .
- Cigarette smoking, Kidney function, and mortality after live donor Kidney transplant.
- The independent association between serum uric acid and graft outcomes after Kidney transplantation.
- Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
- Relative plasma volume monitoring and blood pressure control: an overlooked opportunity to achieve dry weight in the hemodialysis patient.
- A study of renal outcomes in African American living Kidney donors.
- Hypertension and the Kidney: perspectives on the relationship of Kidney disease and cardiovascular disease.
- Optimal dietary strategies for reducing incident Hypertension.
- Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 Diabetes: the SANDS trial.
- Thiazolidinediones and cardiovascular events in high-risk patients with type-2 Diabetes mellitus: a comparison with other oral antidiabetic agents.
- What is left ventricular hypertrophy and is there a reason to regress left ventricular hypertrophy?
- Gauging adequacy of cardiovascular Disease treatment: importance of estimating glomerular filtration rate and time-varying albuminuria.
- The frequency of hyperkalemia and its significance in chronic Kidney disease.
- Renin angiotensin system inhibition in the older person: a review.
- Beta-blockers in the treatment of Hypertension: are there clinically relevant differences?
- Minimizing the risk of Chronic allograft nephropathy.
- Assessing the blood pressure-lowering efficacy of antiHypertensive medications: which blood pressures should we use?
- Prescribing trends and drug budget impact of the ARBs in the UK.
- The detrimental effect of poor early graft function after laparoscopic live donor nephrectomy on graft outcomes.
- Predictors of compliance With antihypertensive therapy in a high-risk medicaid population.
- The renoprotective effects of RAS inhibition: focus on prevention and treatment of chronic Kidney disease.
- Ethnic disparities, hospital quality, and discharges against medical advice among patients with cardiovascular Disease.
- Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 Diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.
- Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 Diabetes mellitus status...
- Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
- Are we "ONTARGET" yet With regard to optimal antihypertensive regimens?
- Renal consequences of prostaglandin inhibition in heart Failure.
Schools
Virginia Commonwealth University School Of Medicine
Waterbury HospYale New Hav
Brigham Womens Hospital
Procedures Preformed
- Hemodialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Alkalosis
- Amyloidosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Top MD
Education
-
Brigham and Women's Hospital -
University of Virginia School of Medicine
Hospital
-
University of Maryland Medical Center
Drug Facts
| NPI NUMBER | 1316985237 | |
| NPPES Provider LastName | WEIR | |
| NPPES Provider FirstName | MATTHEW | |
| NPPES Provider ZIPCode | 212011544 | |
| NPPES Provider State | MD | |
| Specialty Description | Nephrology | |
| Total Claim Count | 343.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1316985237 |
| Last Name Of The Provider | WEIR |
| First Name Of The Provider | MATTHEW |
| View All |
Similar Doctors
|
|
Dr. Robert C. Greenwall Jr., MD |
|
|
Dr. Feras Karadsheh, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sudhi Chintrisna, MD |
|
|
Dr. Hamid Rabb, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Javed Rahmat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aiman S. Shammas, MD |
|
|
Dr. Edward J. Weinman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph M. Nogueira, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harry H. Choi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rohini Adhikarla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Victor C. Onyejiaka, MD
This Doctor is OpenDoctor Recommended.
|